Remove 2012 Remove BioTech Remove Medicare Remove Pharmaceuticals
article thumbnail

Will Foot Ulcer Treatment Survive Medicare Rollback?

Insulin Nation

A state-of-the-art wound therapy that prevents amputations is under threat from proposed cuts in Medicare reimbursement rates, according to regenerative medicine experts. Shire Pharmaceuticals has created Dermagraft, a similar human cell-based dressing that also has become popular for treating diabetic foot ulcers.